Cargando…

Formaldehyde exposure and leukemia risk: a comprehensive review and network-based toxicogenomic approach

Formaldehyde is a widely used but highly reactive and toxic chemical. The International Agency for Research on Cancer classifies formaldehyde as a Group 1 carcinogen, based on nasopharyngeal cancer and leukemia studies. However, the correlation between formaldehyde exposure and leukemia incidence is...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Doo Seok, Kim, Hyun Soo, Jung, Jong-Hyeon, Lee, Cheol Min, Ahn, Yeon-Soon, Seo, Young Rok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042688/
https://www.ncbi.nlm.nih.gov/pubmed/33845901
http://dx.doi.org/10.1186/s41021-021-00183-5
Descripción
Sumario:Formaldehyde is a widely used but highly reactive and toxic chemical. The International Agency for Research on Cancer classifies formaldehyde as a Group 1 carcinogen, based on nasopharyngeal cancer and leukemia studies. However, the correlation between formaldehyde exposure and leukemia incidence is a controversial issue. To understand the association between formaldehyde exposure and leukemia, we explored biological networks based on formaldehyde-related genes retrieved from public and commercial databases. Through the literature-based network approach, we summarized qualitative associations between formaldehyde exposure and leukemia. Our results indicate that oxidative stress-mediated genetic changes induced by formaldehyde could disturb the hematopoietic system, possibly leading to leukemia. Furthermore, we suggested major genes that are thought to be affected by formaldehyde exposure and associated with leukemia development. Our suggestions can be used to complement experimental data for understanding and identifying the leukemogenic mechanism of formaldehyde. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41021-021-00183-5.